Mark Nicolls
Pulmonary Disease · Stanford Health Care
Credentials: · · ·
History
- 1993–1996
1993–1996
Research
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Review · European Respiratory Journal · 2019 · 1,055 citations
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Review · Circulation Research · 2014 · Last of 4 authors · 854 citations
Temporal response of the human virome to immunosuppression and antiviral therapy
Cell · 2013 · 394 citations
- NV
26 papers
21 papers
18 papers
13 papers
12 papers
11 papers
11 papers
11 papers · 1 as a fellow
Grants
- 2017–2028
BMPR2, Monocytes and Macrophages in Pulmonary Artery Hypertension
National Heart, Lung, and Blood Institute · R01
PI · $4.9M · Stanford University
- 2021–2027
Regulatory T Cells and Pulmonary Hypertension
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.5M · Palo Alto Veterans Instit for Research
- 2022–2027
Vaccination Responses in Lung Transplant Recipients
National Heart, Lung, and Blood Institute · U01
Contact PI · $2.1M · Stanford University
- 2016–2026
Stanford Training Program in Lung Biology
National Heart, Lung, and Blood Institute · T32
Contact PI · $3.2M · Stanford University
Clinical trials
- 2011–2019
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)